Contraception Clinical Trial
Official title:
Randomised Controlled Trial of the Effect of Additional Spermicidal Lubrication on Condom Failure
This RCT compares the clinical and non clinical condom failure rate among condom using heterosexual couples with and without externally applied additional spermicidal lubricant. The hypothesis is that breakage and slippage rates will be reduced.
A recent retrospective cohort study of 1006 subjects reported a marked reduction in condom
failure amongst users applying additional lubrication. Improving the reliability of condoms
would reduce the incidence of unwanted pregnancies and STI's (and hence health and social
costs). This trial investigates the relative risk reduction amongst couples applying
additional spermicidal lubrication to condoms, other factors associated with condom failure,
the acceptability and side effects of additional spermicide and its cost effectiveness.
200 regular condom users will be recruited from family planning clinics and other community
sources. A randomised, controlled investigator blinded, crossover design is being used.
Participants will be reviewed at 3 and 6 months. Couples will be randomised to start either
with latex condoms alone (Durex Extra Safe) or with additional Duragel (nonoxynol-9
contracceptive gel) applied to the outside of the condom prior to initial penetration.
Participants are heterosexual couples using condoms for vaginal non-commercial intercourse
in stable relationships of at least 3 months duration. Those under 18, or unable to provide
data due to communication difficulties will be excluded from the trial.
Data will be collected by questionnaires for all subjects on their contraceptive and STI
history, key demographic, social and behavioural factors relevant to condom failure risk at
baseline. At crossover and trial end the rate and types of condom failure, side effects and
acceptability of additional spermicide, and health service and subject costs are collected.
A random sample of subjects also participate in a detailed semi-structured interview at the
end of the study, covering their recent experiences of condom failure, and opinions about
condoms in general, including the use of additional spermicide. These qualitative findings
will then be discussed in patient and professional focus groups as a proxy for respondent
checking and data triangulation.
The research will provide valuable, detailed information on factors associated with condom
failure. Confirmation of the previous finding of the protective effects of additional
spermicide would have a potentially major international impact in the fields of family
planning and infectious diseases.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |